Winship treats first lung cancer patient with T-cell receptor

Frontiers Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects

Biomedicines, Free Full-Text

PDF) Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

PDF) Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study

Incremental Gains Toward Better Outcomes in Small Cell Lung Cancer - The ASCO Post

How Science Became Hope 50th Anniversary of the National Cancer Act

Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment - ScienceDirect

History of Winship Winship Cancer Institute

Emory Winship Cancer Institute Magazine Spring 2016 by Emory University - Issuu

Cancers, Free Full-Text

Spring/Summer 2020 Emory Health Digest